BACKGROUND: Atopic asthmatic patients are reported to be more sensitive to the effects of environmental endotoxin (LPS) than healthy volunteers (HVs). It is unknown whether this sensitivity is due to dysregulated inflammatory responses after LPS exposure in atopic asthmatic patients. OBJECTIVE: We sought to test the hypothesis that atopic asthmatic patients respond differentially to inhaled LPS challenge compared with HVs. METHODS: Thirteen allergic asthmatic (AA) patients and 18 nonallergic nonasthmatic subjects (healthy volunteers [HVs]) underwent an inhalation challenge to 20,000 endotoxin units of Clinical Center Reference Endotoxin (LPS). Induced sputum and peripheral blood were obtained at baseline and 6 hours after inhaled LPS challenge. Sputum and blood samples were assayed for changes in inflammatory cell numbers and cytokine and cell-surface marker levels on monocytes and macrophages. RESULTS: The percentage of neutrophils in sputum (%PMN) in induced sputum similarly and significantly increased in both HVs and AA patients after inhaled LPS challenge. However, the absolute numbers of leukocytes and PMNs recruited to the airways were significantly lower in AA patients compared with those seen in HVs with inhaled LPS challenge. Sputum levels of IL-6 and TNF-α were significantly increased in both cohorts, but levels of IL-1β and IL-18 were only significantly increased in the HV group. Cell-surface expression of Toll-like receptors 4 and 2 were significantly enhanced only in the HV group. CONCLUSIONS: The airway inflammatory response to inhaled LPS challenge is blunted in AA patients compared with that seen in HVs and accompanied by reductions in airway neutrophilia and inflammasome-dependent cytokine production. These factors might contribute to increased susceptibility to airway microbial infection or colonization in AA patients.
BACKGROUND: Atopic asthmatic patients are reported to be more sensitive to the effects of environmental endotoxin (LPS) than healthy volunteers (HVs). It is unknown whether this sensitivity is due to dysregulated inflammatory responses after LPS exposure in atopic asthmatic patients. OBJECTIVE: We sought to test the hypothesis that atopic asthmatic patients respond differentially to inhaled LPS challenge compared with HVs. METHODS: Thirteen allergic asthmatic (AA) patients and 18 nonallergic nonasthmatic subjects (healthy volunteers [HVs]) underwent an inhalation challenge to 20,000 endotoxin units of Clinical Center Reference Endotoxin (LPS). Induced sputum and peripheral blood were obtained at baseline and 6 hours after inhaled LPS challenge. Sputum and blood samples were assayed for changes in inflammatory cell numbers and cytokine and cell-surface marker levels on monocytes and macrophages. RESULTS: The percentage of neutrophils in sputum (%PMN) in induced sputum similarly and significantly increased in both HVs and AA patients after inhaled LPS challenge. However, the absolute numbers of leukocytes and PMNs recruited to the airways were significantly lower in AA patients compared with those seen in HVs with inhaled LPS challenge. Sputum levels of IL-6 and TNF-α were significantly increased in both cohorts, but levels of IL-1β and IL-18 were only significantly increased in the HV group. Cell-surface expression of Toll-like receptors 4 and 2 were significantly enhanced only in the HV group. CONCLUSIONS: The airway inflammatory response to inhaled LPS challenge is blunted in AA patients compared with that seen in HVs and accompanied by reductions in airway neutrophilia and inflammasome-dependent cytokine production. These factors might contribute to increased susceptibility to airway microbial infection or colonization in AA patients.
Authors: R O Crapo; R Casaburi; A L Coates; P L Enright; J L Hankinson; C G Irvin; N R MacIntyre; R T McKay; J S Wanger; S D Anderson; D W Cockcroft; J E Fish; P J Sterk Journal: Am J Respir Crit Care Med Date: 2000-01 Impact factor: 21.405
Authors: Willie June Brickey; Neil E Alexis; Michelle L Hernandez; William Reed; Jenny P Y Ting; David B Peden Journal: J Allergy Clin Immunol Date: 2011-08-25 Impact factor: 10.793
Authors: Jia Zhong; Bruce Urch; Mary Speck; Brent A Coull; Petros Koutrakis; Peter S Thorne; James Scott; Ling Liu; Robert D Brook; Behrooz Behbod; Heike Gibson; Frances Silverman; Murray A Mittleman; Andrea A Baccarelli; Diane R Gold Journal: Hypertension Date: 2015-06-29 Impact factor: 10.190
Authors: Aimee Hoskins; Sara Reiss; Pingsheng Wu; Ning Chen; Wei Han; Rui-hong Do; Rasul Abdolrasulnia; Ryszard Dworski Journal: Am J Respir Crit Care Med Date: 2012-11-29 Impact factor: 21.405
Authors: Jeppe M Larsen; Hanieh S Musavian; Tariq M Butt; Camilla Ingvorsen; Anna H Thysen; Susanne Brix Journal: Immunology Date: 2015-02 Impact factor: 7.397
Authors: Michelle L Hernandez; James G Wagner; Aline Kala; Katherine Mills; Heather B Wells; Neil E Alexis; John C Lay; Qing Jiang; Hongtao Zhang; Haibo Zhou; David B Peden Journal: Free Radic Biol Med Date: 2013-02-09 Impact factor: 7.376
Authors: William D Bennett; Margaret Herbst; Kirby L Zeman; Jihong Wu; Michelle L Hernandez; David B Peden Journal: J Allergy Clin Immunol Date: 2012-10-25 Impact factor: 10.793
Authors: Michelle L Hernandez; Katherine Mills; Martha Almond; Krista Todoric; Maria M Aleman; Hongtao Zhang; Haibo Zhou; David B Peden Journal: J Allergy Clin Immunol Date: 2014-09-05 Impact factor: 10.793